Assessing the use of a micro-sampling device for measuring blood protein levels in healthy subjects and COVID-19 patients
Abstract
Venous phlebotomy performed by trained personnel is critical for patient diagnosis and monitoring of chronic disease, but has limitations in resource-constrained settings, and represents an infection control challenge during outbreaks. Self-collection devices have the potential to shift phlebotomy closer to the point of care, supporting telemedicine strategies and virtual clinical trials. Here we assess a capillary blood micro-sampling device, the Tasso Serum Separator Tube (SST), for measuring blood protein levels in healthy subjects and non-hospitalized COVID-19 patients.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Aug 10, 2022
- Source ID
- 10.1371/journal.pone.0272572
Entities
People
- Carmen M. Paguirigan
- Catherine F. T. Uyehara
- Cdr Cynthia S. Sikorski
- Christopher A. Myers
- Col Viseth Ngauy
- Danielle V. Clark
- Deborah A. Striegel
- John Stephen Dumler
- Joost Brandsma
- Josh G. Chenoweth
- Kelsey O'Connor
- Kevin L Schully
- Melissa K. Gregory
- Paul W. Blair
- Rittal Mehta
- Subramaniam Krishnan
- Susan A. Reichert-scrivner
Organizations
- Bureau of Medicine and Surgery
- Johns Hopkins School of Medicine